Why Moderna Stock Surged Today
Shares of Moderna (NASDAQ: MRNA) popped on Wednesday after the biotech leader announced positive clinical trial results for its experimental skin cancer vaccine, developed with healthcare giant .
By the close of trading, Moderna's stock price was up more than 15%.
Image source: Getty Images.
Source Fool.com
Moderna Inc. Stock
€59.24
0.250%
Based on 9 Buy predictions and 9 Sell predictions the sentiment towards Moderna Inc. is rather balanced.
A target price of 21 € results in a potential of -64.55% which would mean heavy losses compared to the current price of 59.24 € for Moderna Inc..
